- Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen
-
Huang CT, Tseng TC
- KMID: 2554417
- Clin Mol Hepatol.
- 2024 Apr;30(2):154-156.
- doi: 10.3350/cmh.2024.0120
-
- CITED
-
- Close
- SHARE
-
- Close
- Another oral antiviral treatment, but still far away from hepatitis B virus cure
-
Tseng TC
- KMID: 2514769
- Clin Mol Hepatol.
- 2021 Apr;27(2):281-282.
- doi: 10.3350/cmh.2021.0072
-
- CITED
-
- Close
- SHARE
-
- Close
- Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
-
Lin HY, Tseng TC
- KMID: 2528247
- Clin Mol Hepatol.
- 2022 Apr;28(2):181-182.
- doi: 10.3350/cmh.2022.0028
-
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
-
Huang SC, Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, Liu CJ
- KMID: 2515849
- Gut Liver.
- 2021 May;15(3):451-458.
- doi: 10.5009/gnl20218
Background/Aims: Fatty liver disease is defined as a cluster of diseases with heterogeneous etiologies, and its definition continues to evolve. The novel conceptional criteria for metabolic dysfunction-associated fatty liver disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
-
Wu JW, Kao JH, Tseng TC
- KMID: 2520835
- Clin Mol Hepatol.
- 2021 Oct;27(4):524-534.
- doi: 10.3350/cmh.2021.0012
Patients with chronic hepatitis B virus (HBV) infection are at risk of developing hepatocellular carcinoma (HCC), and serum markers reflecting viral replication are potential predictors for HCC development. Besides the... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
-
Lan TY, Lin YC, Tseng TC, Yang HC, Kao JH, Cheng CF, Lee TJ, Huang SC, Lu CH, Li KJ, Hsieh SC
- KMID: 2540417
- Gut Liver.
- 2023 Mar;17(2):288-298.
- doi: 10.5009/gnl210551
Background/Aims: Rituximab is known to be associated with high hepatitis B virus (HBV) reactivation rate in patients with resolved HBV infection and hematologic malignancy. However, data regarding HBV reactivation (HBVr) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics, Genetic Features, and Long-Term Outcome of Wilson’s Disease in a Taiwanese Population: An 11-Year Follow-Up Study
-
Fan SP, Kuo YC, Lee NC, Chien YH, Hwu WL, Huang YH, Lin HI, Tseng TC, Su TH, Tzeng SR, Hsu CT, Chen HL, Lin CH, Ni YH
- KMID: 2542421
- J Mov Disord.
- 2023 May;16(2):168-179.
- doi: 10.14802/jmd.22161
ObjectiveaaWilson’s disease (WD) is a rare genetic disorder of copper metabolism, and longitudinal follow-up studies are limited. We performed a retrospective analysis to determine the clinical characteristics and long-term outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
